Mycobacterium haemophilum: A rare cause of endophthalmitis

Retina

Volumn 27, Issue 8, 2007, Pages 1148-1151

  Modi, Dimple ^a   Pyatetsky, Dmitry ^a   Edward, Deepak P ^a   Ulanski, Lawrence J ^a   Pursell, Kenneth J ^b   Tessler, Howard H ^a   Goldstein, Debra A ^a,c  

^a University of Illinois Chicago   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BRIMONIDINE; CORTICOSTEROID; CYCLOSPORIN; DORZOLAMIDE PLUS TIMOLOL; ETHAMBUTOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ISONIAZID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PYRIDOXINE; PYRIMETHAMINE; RIFAMPICIN; VALACICLOVIR;

ACID FAST BACTERIUM; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; ENDOPHTHALMITIS; EYE BIOPSY; GLAUCOMA; HEART TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; IRIDOCYCLITIS; MALE; MYCOBACTERIUM HAEMOPHILUM; VITRECTOMY;

AGED; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE ENUCLEATION; EYE INFECTIONS, BACTERIAL; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS; SKIN DISEASES, BACTERIAL; VITREOUS BODY;

EID: 37349017924     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318030e622     Document Type: Article

References (10)

1. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. Mycobacterium haemophilum sp. Nov., a new pathogen of humans. Int J Syst Bacteriol 1978;28:67-75.
2. Straus WL, Ostroff SM, Jernigan DB, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994;120:118-125.
3. Fairhurst RM, Kubak BM, Pegues DA,. Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant 2002;2:476-479.
4. Scott IU, Lieb DF, Flynn HW Jr., Dessouki A, Murray TG, Miller D. Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol 2003;121:573-576.
5. Busam KJ, Kiehn TE, Salob SP, Myskowski PL. Histologic reactions to cutaneous infections by Mycobacterium haemophilum. Am J Surg Pathol 1999;23:1379-1385.
6. Mustafa AS, Abal AT, Chugh TD. Detection of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria by multiplex polymerase chain reactions. East Mediter Health J 1999;5:61-70.
7. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001;33:330-337.
8. Padilla E, Manterola JM, Gonzalez V, et al. Rapid detection of several mycobacterial species using a polymerase chain reaction reverse hybridization assay. Eur J Clin Microbiol Infect Dis 2001;20:661-665.
9. Okhravi N, Guest S, Matheson MM, et al. Assessment of the effect of oral clarithromycin on visual outcome following presumed bacterial endophthalmitis. Curr Eye Res 2000;21:691-702.
10. Kedzierska K, Mak J, Mijch A, et al. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J Infect Dis 2000;181:390-394.